看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
4 C; P9 u% ]* u* \
1 v. p( f! w, i! {2 r; n! [' Z6 q9 K& Q3 `! G* g. k9 O3 t+ i
Currently available feasibility data for possible combination strategies.
. f; K* v+ [2 P. P————————————————————————————————7 H7 q$ U* h4 k( y* z/ Z8 G# d6 H
Combination Feasibility according to preliminary data 9 i5 z: j0 q- u0 z
——————————————————————————————————8 [4 K i4 x7 V* z/ R8 |
Bevacizumab + sorafenib Yes, reduced dose / I' n& {8 G5 I5 ~9 q" o
Bevacizumab + sunitinib† No ! t6 [& J) j: e6 m8 |
Bevacizumab + temsirolimus Yes ; r" e$ t K6 E9 X7 {
Bevacizumab + everolimus Yes
5 \* `# C! Y. u8 O& m1 v/ N5 @% OSorafenib + sunitinib ?
( g a/ _1 R; U0 B, s PSorafenib + temsirolimus Yes, reduced dose : k, U: M& e0 P# p
Sorafenib + everolimus Yes, reduced dose
7 `- \- @& a6 J: fSunitinib + temsirolimus† No $ f1 _+ u3 F- H$ a% ?0 |
Sunitinib + everolimus ? * V f. ^" [4 O6 R9 g( w
Temsirolimus + everolimus ?
2 r( Z* h: f9 a7 @3 [# y& t, p( S————————————————————% e& k' |+ n+ Y/ G+ \
†Led to US FDA warning.: g/ ?+ R1 R; ?1 W
?: As yet unattempted combination.9 f k% g; @- i8 u+ U- B' G( U1 H
|